We previously reported that constitutive release of sCD200 from CLL cells was partially reduced by GM6001, a global inhibitor of metalloproteases and silencing of ADAM28, supporting the hypothesis that sCD200 is the product of ectodomain shedding [19, 20]. The gene discussed is ADAM28; the disease is B-cell chronic lymphocytic leukemia.